Following last summer’s discovery of nitrosamine impurities in angiotensin II receptor blocker (ARB) drugs, which led to numerous recalls of the blood pressure drugs, the US Food and Drug ...
Patients who start their blood pressure treatment with ARB drugs continue with the same medicine to a greater extent than patients who start out with other drugs. Choosing the right drug from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results